✦ LIBER ✦

Elevated levels of soluble ICAM-1 in serum of patients with acute myeloid leukemia undergoing bone marrow transplantation

✍ Scribed by Maeda, Yasuhiro; Chihara, Junichi; Horiuchi, Fusanari; Miyatake, Jun-ichi; Tatsumi, Yoichi; Urase, Fumiaki; Irimajiri, Kiyohiro; Nakajima, Shigenori; Horiuchi, Atsushi

Publisher: John Wiley and Sons
Year: 1996
Tongue: English
Weight: 177 KB
Volume: 52
Category: Article
ISSN: 0361-8609
DOI: 10.1002/(sici)1096-8652(199607)52:3<227::aid-ajh18>3.0.co;2-c

No coin nor oath required. For personal study only.

✦ Synopsis

Serum soluble ICAM-1 concentrations were measured in 10 patients with or without chronic graft-vs.-host disease (GVHD) after allogeneic bone marrow transplantation. The serum soluble ICAM-1 levels in the patients with chronic GVHD were significantly higher than that in the patients without chronic GVHD. The data indicated that serum soluble ICAM-1 is a useful parameter for predicting chronic GVHD.

📜 SIMILAR VOLUMES

Non-random involvement of chromosome 13

Non-random involvement of chromosome 13 in patients with persistent or relapsed disease after bone-marrow transplantation for chronic myeloid leukemia

✍ Andrew Chase; Julie Pickard; Richard Szydlo; Stephanie Coulthard; John M. Goldma 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 2 views

Chronic myeloid leukemia (CML) patients with persistent or relapsed disease following bone-marrow transplantation (BMT) usually show both clonal and non-clonal cytogenetic changes in addition to the Philadelphia (Ph) translocation. These changes are presumably due to conditioning prior to transplant

Analysis of factors related to the occur

Analysis of factors related to the occurrence of chronic disseminated candidiasis in patients with acute leukemia in a non–bone marrow transplant setting : A follow-up study

✍ Sabah Sallah; Jim Y. Wan; Nam P. Nguyen; Paul Vos; George Sigounas 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB 👁 2 views

BACKGROUND. Chronic disseminated candidiasis (CDC) is a serious complication of treatment in patients with acute leukemia. Although some general risk factors are known to predispose to systemic fungal infections, few studies have addressed the relevance of certain clinical and laboratory features in